Filing Details

Accession Number:
0001209191-22-016227
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 16:19:19
Reporting Period:
2022-03-02
Accepted Time:
2022-03-04 16:19:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512985 A. Michael Desjardin C/O Horizon Therapeutics Plc,
70 Saint Stephen?S Green
Dublin L2 D02 E2X4
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-03-02 21,482 $97.05 116,078 No 4 S Direct
Ordinary Shares Disposition 2022-03-02 13,518 $97.42 102,560 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.24 to $97.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.26 to $97.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.